Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Hunzelmann

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|June 21, 2020
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patientsLorenzo Beretta, Guillermo Barturen, Barbara Vigone, et al.
Rheumatology (Oxford, England)|June 19, 2021
Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohortMichael Hughes, Calvin Heal, Jörg Henes, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2026
Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR databaseCorrado Campochiaro, Marie-Elise Truchetet, Madelon Vonk, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 19, 2008
Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseasesMichael Hertl, Detlef Zillikens, Luca Borradori, et al.
Rheumatology (Oxford, England)|April 16, 2026
Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosisMarc Schmalzing, Pia Moinzadeh, Jithmi Weliwitage, et al.
Zeitschrift Fur Rheumatologie|November 11, 2025
[S2k guidelines on diagnostics and treatment of systemic sclerosis : Abridged version]Jörg C Henes, Swantje Arndt, Melanie Berger, et al.
Rheumatology (Oxford, England)|April 26, 2020
Older age onset of systemic sclerosis - accelerated disease progression in all disease subsetsPia Moinzadeh, Kathrin Kuhr, Elise Siegert, et al.
Zeitschrift Fur Rheumatologie|November 11, 2025
[S2k guidelines on diagnostics and treatment of systemic sclerosis : Full version]Jörg C Henes, Swantje Arndt, Melanie Berger, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|June 21, 2020
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patientsLorenzo Beretta, Guillermo Barturen, Barbara Vigone, et al.
Rheumatology (Oxford, England)|June 19, 2021
Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohortMichael Hughes, Calvin Heal, Jörg Henes, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2026
Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR databaseCorrado Campochiaro, Marie-Elise Truchetet, Madelon Vonk, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 19, 2008
Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseasesMichael Hertl, Detlef Zillikens, Luca Borradori, et al.
Rheumatology (Oxford, England)|April 16, 2026
Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosisMarc Schmalzing, Pia Moinzadeh, Jithmi Weliwitage, et al.
Zeitschrift Fur Rheumatologie|November 11, 2025
[S2k guidelines on diagnostics and treatment of systemic sclerosis : Abridged version]Jörg C Henes, Swantje Arndt, Melanie Berger, et al.
Rheumatology (Oxford, England)|April 26, 2020
Older age onset of systemic sclerosis - accelerated disease progression in all disease subsetsPia Moinzadeh, Kathrin Kuhr, Elise Siegert, et al.
Zeitschrift Fur Rheumatologie|November 11, 2025
[S2k guidelines on diagnostics and treatment of systemic sclerosis : Full version]Jörg C Henes, Swantje Arndt, Melanie Berger, et al.
Pageof 15